252 related articles for article (PubMed ID: 30999152)
1. Current status of nanomaterial-based treatment for hepatocellular carcinoma.
Baig B; Halim SA; Farrukh A; Greish Y; Amin A
Biomed Pharmacother; 2019 Aug; 116():108852. PubMed ID: 30999152
[TBL] [Abstract][Full Text] [Related]
2. Surface Engineering of Nanoparticles for Targeted Delivery to Hepatocellular Carcinoma.
Lu J; Wang J; Ling D
Small; 2018 Feb; 14(5):. PubMed ID: 29251419
[TBL] [Abstract][Full Text] [Related]
3. Application of Nanotechnology in the Diagnosis and Therapy of Hepatocellular Carcinoma.
Hou XY; Jiang G; Yang CS; Tang JQ; Wei ZP; Liu YQ
Recent Pat Anticancer Drug Discov; 2016; 11(3):322-31. PubMed ID: 26955964
[TBL] [Abstract][Full Text] [Related]
4. Nanomedicine in management of hepatocellular carcinoma: Challenges and opportunities.
Mohamed NK; Hamad MA; Hafez MZ; Wooley KL; Elsabahy M
Int J Cancer; 2017 Apr; 140(7):1475-1484. PubMed ID: 27861850
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in hepatocellular carcinoma-targeted nanoparticles.
Liu X; Bai Y; Zhou B; Yao W; Song S; Liu J; Zheng C
Biomed Mater; 2024 May; 19(4):. PubMed ID: 38697209
[TBL] [Abstract][Full Text] [Related]
6. Nanocarrier-Based Tumor-Targeting Drug Delivery Systems for Hepatocellular Carcinoma Treatments: Enhanced Therapeutic Efficacy and Reduced Drug Toxicity.
Tian T; Ruan J; Zhang J; Zhao CX; Chen D; Shan J
J Biomed Nanotechnol; 2022 Mar; 18(3):660-676. PubMed ID: 35715919
[TBL] [Abstract][Full Text] [Related]
7. Advanced therapeutics avenues in hepatocellular carcinoma: a novel paradigm.
Javed ; Yadav S
Med Oncol; 2023 Jul; 40(8):239. PubMed ID: 37442842
[TBL] [Abstract][Full Text] [Related]
8. Nanotechnology for therapy and imaging of liver diseases.
Reddy LH; Couvreur P
J Hepatol; 2011 Dec; 55(6):1461-6. PubMed ID: 21801699
[TBL] [Abstract][Full Text] [Related]
9. Strategies to optimize siRNA delivery to hepatocellular carcinoma cells.
Scarabel L; Perrone F; Garziera M; Farra R; Grassi M; Musiani F; Russo Spena C; Salis B; De Stefano L; Toffoli G; Rizzolio F; Tonon F; Abrami M; Chiarappa G; Pozzato G; Forte G; Grassi G; Dapas B
Expert Opin Drug Deliv; 2017 Jun; 14(6):797-810. PubMed ID: 28266887
[TBL] [Abstract][Full Text] [Related]
10. Aptamer-functionalized nanomaterials (AFNs) for therapeutic management of hepatocellular carcinoma.
Yin X; Rong J; Shao M; Zhang S; Yin L; He Z; Wang X
J Nanobiotechnology; 2024 May; 22(1):243. PubMed ID: 38735927
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic potential of small interfering RNAs/micro interfering RNA in hepatocellular carcinoma.
Farra R; Grassi M; Grassi G; Dapas B
World J Gastroenterol; 2015 Aug; 21(30):8994-9001. PubMed ID: 26290628
[TBL] [Abstract][Full Text] [Related]
12. Treatment options for unresectable HCC with a focus on SIRT with Yttrium-90 resin microspheres.
Wang EA; Stein JP; Bellavia RJ; Broadwell SR
Int J Clin Pract; 2017 Nov; 71(11):. PubMed ID: 28758319
[TBL] [Abstract][Full Text] [Related]
13. Polo-like Kinase 1-targeting Chitosan Nanoparticles Suppress the Progression of Hepatocellular Carcinoma.
Wang D; Chang R; Wang G; Hu B; Qiang Y; Chen Z
Anticancer Agents Med Chem; 2017; 17(7):948-954. PubMed ID: 27671301
[TBL] [Abstract][Full Text] [Related]
14. Advances in liver-directed gene therapy for hepatocellular carcinoma by non-viral delivery systems.
Ding B; Li T; Zhang J; Zhao L; Zhai G
Curr Gene Ther; 2012 Apr; 12(2):92-102. PubMed ID: 22348553
[TBL] [Abstract][Full Text] [Related]
15. Nanotechnology Based Approach for Hepatocellular Carcinoma Targeting.
Alhalmi A; Beg S; Kohli K; Waris M; Singh T
Curr Drug Targets; 2021; 22(7):779-792. PubMed ID: 33302831
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal assessment of ultrasound-guided complementary microRNA therapy of hepatocellular carcinoma.
Chowdhury SM; Lee T; Bachawal SV; Devulapally R; Abou-Elkacem L; Yeung TA; Wischhusen J; Tian L; Dahl J; Paulmurugan R; Willmann JK
J Control Release; 2018 Jul; 281():19-28. PubMed ID: 29758233
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma: Preclinical and clinical applications of nanotechnology with the potential role of carbohydrate receptors.
Batheja S; Sahoo RK; Tarannum S; Vaiphei KK; Jha S; Alexander A; Goyal AK; Gupta U
Biochim Biophys Acta Gen Subj; 2023 Oct; 1867(10):130443. PubMed ID: 37573973
[TBL] [Abstract][Full Text] [Related]
18. Current approaches to the diagnosis and management of hepatocellular carcinoma.
Perry JF; Poustchi H; George J; Farrell GC; McCaughan GW; Strasser SI
Clin Exp Med; 2005 May; 5(1):1-13. PubMed ID: 15928877
[TBL] [Abstract][Full Text] [Related]
19. RNA interference-mediated prevention and therapy for hepatocellular carcinoma.
Romano PR; McCallus DE; Pachuk CJ
Oncogene; 2006 Jun; 25(27):3857-65. PubMed ID: 16799627
[TBL] [Abstract][Full Text] [Related]
20. Tumor-penetrating codelivery of siRNA and paclitaxel with ultrasound-responsive nanobubbles hetero-assembled from polymeric micelles and liposomes.
Yin T; Wang P; Li J; Wang Y; Zheng B; Zheng R; Cheng D; Shuai X
Biomaterials; 2014 Jul; 35(22):5932-43. PubMed ID: 24746965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
